Skip to content

Evaluation of the efficacy and safety of test foods for older adults

Evaluation of the efficacy and safety of test foods for older adults - Evaluation of the efficacy and safety of test foods for older adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059194
Enrollment
52
Registered
2026-03-31
Start date
2025-09-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Oral intake of the test food for 48 weeks with an exercise intervention Oral intake of the placebo food for 48 weeks with an exercise intervention Oral intake of the test food for 48 weeks without an

Sponsors

Morinaga & Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males or females aged 50-79 years who had provided informed consent. 2) Ability to perform the physical activities required for the conduct of the study. 3) Ability to provide their own smartphone and email address, and to download and use the program/app necessary for the study on that smartphone. 4) Ability to understand the study purpose and procedures, and participate voluntarily.

Exclusion criteria

Exclusion criteria: 1)A total HDS-R score of 20 or less at screening. 2)Difficulty with color discrimination or other problems that interfere with cognitive testing. 3)Unable to complete web questionnaires. 4)Current, prior, or suspected dementia, psychiatric, neurological, or cerebrovascular disease. 5)Current menopausal disorder. 6)Taking medications that could affect the study results. 7)Have undergone cognitive testing within 3 months before screening, or plan non-study cognitive testing during the study. 8)Having a disorder affecting motor function and currently receiving pharmacological treatment. 9)Regularly engaging in activities that influence motor function. 10)Absolute contraindication to exercise therapy or exercise stress testing. 11)Unable to perform measurements or exercise due to injury or illness. 12)Engage regularly in moderate-to-vigorous exercise totaling 3 hours or more per week. 13)Planned unavoidable intense exercise during the study. 14)Have major surgery planned during the study or are awaiting major surgery. 15)Current or past serious illnesses (e.g., malignant neoplasm, diabetes, liver, kidney, or heart disease). 16)Are at risk of developing an allergy related to the study. 17)Regularly using dietary supplements or medications containing the study's active ingredient. 18)Regularly consuming supplements intended to affect cognition, motor, or immune function. 19)Will have multiple occurrences of irregular lifestyle during the study. 20)Plan to change lifestyle habits during the study unrelated to participation in this study. 21)Regular heavy alcohol consumption. 22)Smoke 21 or more cigarettes per day. 23)Participation in another clinical trial within 1 month before consent, or planned during the study. 24)Pregnant or breastfeeding, or plan pregnancy during the study. 25)Judged unsuitable as a study subject based on responses to questionnaire or screening. 26)Any other reason the principal investigator considers the candidate unsuitable for participation.

Design outcomes

Primary

MeasureTime frame
6-minute walk test

Secondary

MeasureTime frame
grip strength, measurement of blood markers, cognitive assessment score

Countries

Japan

Contacts

Public ContactShinpei Kawakami

Morinaga & Co., Ltd. Health Science and Research Center, R&D institute

s-kawakami-jf@morinaga.co.jp045-571-6140

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026